Typ : |
tidningen |
internet länkar : |
https://doi.org/10.1007/s40259-019-00342-9 |
|
forskargrupper : |
Grenade - Faculty of Science, Department of Analytical Chemistry |
Författare : |
Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N. |
Titel : |
Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA). |
Hänvisningar : |
Bio Drugs ; 33: 193–205. 2019 |
|
Evidensgrad : |
|
fysikalisk stabilitet : |
|
kemisk stabilitet : |
|
andra metoder : |
|
Kommentarer : |
Proteiner: biologisk aktivitet genom cellodling |
|
Förteckning över substanser
Infliximab
|
|
|
|
|
10 mg/ml |
2-8°C |
|
14 |
|
|
|
|
|
|
10 mg/ml |
2-8°C |
|
14 |
|
|
|
|
|
|
0,4 mg/ml |
2-8°C |
|
14 |
|
|
|
|
|
|
0,4 mg/ml |
2-8°C |
|
14 |
|
|
|
|
|
|
2 mg/ml |
2-8°C |
|
14 |
|
|
|
|
|
|
2 mg/ml |
2-8°C |
|
14 |
|
|
|
|
|